ToxSci Advance Access published online on January 21, 2004
Toxicological Sciences, doi:10.1093/toxsci/kfh067
Toxicological Sciences © Society of Toxicology 2004; all rights reserved
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Molecular Biosciences and Bioengineering, College of Tropical Agriculture and Human Resources, University of Hawaii at Manoa, Honolulu, HI 96822
* To whom correspondence should be addressed. E-mail: pratibha{at}hawaii.edu.
Kava herbal supplements have been recently associated with acute hepatotoxicity, leading to the ban of kava products in approximately a dozen countries around the world. It is suspected that some alkaloids from aerial kava may have contributed to the problem. Traditionally, Pacific Islanders employ primarily the underground parts of the shrub to prepare the kava beverage. However, some kava herbal supplements may contain ingredients from aerial stem peelings. The aim of this project was to test the in vitro effects of a major kava alkaloid, pipermethystine (PM) found mostly in leaves and stem peelings and kavalactones such as 7,8-dihydromethysticin (DHM), desmethoxyyangonin (DMY) that are abundant in the roots. Exposure of human hepatoma cells, HepG2, to 100 µM of PM caused 90% loss in cell viability within 24 h, while 50 µM caused 65% cell death. Similar concentrations of kavalactones did not affect cell viability up to 8 days of treatment. Mechanistic studies indicate that in contrast to kavalactones, PM significantly decreased cellular ATP levels, mitochondrial membrane potential and induced apoptosis as measured by the release of caspase-3 after 24 h of treatment. These observations suggest that PM, rather than kavalactones, is capable of causing cell death, probably in part by disrupting mitochondrial function. Thus, PM may contribute to rare but severe hepatotoxic reactions to kava.
© 2004 Society of Toxicology
In Vitro Toxicology and Alternative Testing
In Vitro Toxicity of Kava Alkaloid, Pipermethystine, in HepG2 Cells as Compared to Kavalactones
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. E. Johnson, F. Kassie, M. G. O'Sullivan, M. Negia, T. E. Hanson, P. Upadhyaya, P. P. Ruvolo, S. S. Hecht, and C. Xing Chemopreventive Effect of Kava on 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone plus Benzo[a]pyrene-Induced Lung Tumorigenesis in A/J Mice Cancer Prevention Research, November 1, 2008; 1(6): 430 - 438. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Wruck, M. E. Gotz, T. Herdegen, D. Varoga, L.-O. Brandenburg, and T. Pufe Kavalactones Protect Neural Cells against Amyloid {beta} Peptide-Induced Neurotoxicity via Extracellular Signal-Regulated Kinase 1/2-Dependent Nuclear Factor Erythroid 2-Related Factor 2 Activation Mol. Pharmacol., June 1, 2008; 73(6): 1785 - 1795. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T.S. Lim, K. Dragull, C.-S. Tang, H. C. Bittenbender, J. T. Efird, and P. V. Nerurkar Effects of Kava Alkaloid, Pipermethystine, and Kavalactones on Oxidative Stress and Cytochrome P450 in F-344 Rats Toxicol. Sci., May 1, 2007; 97(1): 214 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Buenz A BRIEF COMMUNICATION: Hepatocytes Detoxify Atuna racemosa Extract Experimental Biology and Medicine, December 1, 2006; 231(11): 1739 - 1743. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Mathews, A. S. Etheridge, J. L. Valentine, S. R. Black, D. P. Coleman, P. Patel, J. So, and L. T. Burka PHARMACOKINETICS AND DISPOSITION OF THE KAVALACTONE KAWAIN: INTERACTION WITH KAVA EXTRACT AND KAVALACTONES IN VIVO AND IN VITRO Drug Metab. Dispos., October 1, 2005; 33(10): 1555 - 1563. [Abstract] [Full Text] [PDF] |
||||




